Effect of DR and DR6 matching on cadaver kidney transplant survival.
Reyman
T A
TA
Department of Pathology, Mount Carmel Mercy Hospital, Detroit, MI 48235.
Toledo-Pereyra
L H
LH
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D003524:Cyclosporins / Q000627:therapeutic use; D005500:Follow-Up Studies; D006085:Graft Survival / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D015808:HLA-DR6 Antigen / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D010641:Phenotype; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D006684:HLA-DR Antigens; D015808:HLA-DR6 Antigen; D011239:Prednisolone; D001379:Azathioprine